Analyst Ratings for Avid Bioservices (CDMO)

CDMO Rating Summary

CDMO Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CDMO
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $28.25 (+28.2%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/17/2021 RBC Capital
» Updated 6/30/2021
Sean Dodge New Coverage Outperform
(N/A)
27.00
(21.00)
17.68
(22.03)
24.6% Details
11/10/2020 KeyBanc
» Updated 6/30/2021
Paul Knight New Coverage Overweight
(N/A)
28.00
(22.00)
8.35
(22.03)
163.83% Details
Like CDMO Ratings? Also take a look at HGEN, HRTG, COE, ADCT

CDMO Ratings News